Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer
Goodman, O B, Flaig, T W, Molina, A, Mulders, P F A, Fizazi, K, Suttmann, H, Li, J, Kheoh, T, de Bono, J S, Scher, H I
Published in Prostate cancer and prostatic diseases (01.03.2014)
Published in Prostate cancer and prostatic diseases (01.03.2014)
Get full text
Journal Article
Functionalized gold nanorods for thermal ablation treatment of bladder cancer
Cho, S K, Emoto, K, Su, L J, Yang, X, Flaig, T W, Park, W
Published in Journal of biomedical nanotechnology (01.07.2014)
Published in Journal of biomedical nanotechnology (01.07.2014)
Get more information
Journal Article
A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer
Dasari, A., Gore, L., Messersmith, W. A., Diab, S., Jimeno, A., Weekes, C. D., Lewis, K. D., Drabkin, H. A., Flaig, T. W., Camidge, D. R.
Published in Investigational new drugs (01.02.2013)
Published in Investigational new drugs (01.02.2013)
Get full text
Journal Article
Safety and efficacy of the combination of erlotinib and sirolimus for the treatment of metastatic renal cell carcinoma after failure of sunitinib or sorafenib
Flaig, T W, Costa, L J, Gustafson, D L, Breaker, K, Schultz, M K, Crighton, F, Kim, F J, Drabkin, H
Published in British journal of cancer (07.09.2010)
Published in British journal of cancer (07.09.2010)
Get full text
Journal Article
Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL
Graff, J.N., Baciarello, G., Armstrong, A.J., Higano, C.S., Iversen, P., Flaig, T.W., Forer, D., Parli, T., Phung, D., Tombal, B., Beer, T.M., Sternberg, C.N.
Published in Annals of oncology (01.02.2016)
Published in Annals of oncology (01.02.2016)
Get full text
Journal Article
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
Knox, J.J., Barrios, C.H., Kim, T.M., Cosgriff, T., Srimuninnimit, V., Pittman, K., Sabbatini, R., Rha, S.Y., Flaig, T.W., Page, R.D., Beck, J.T., Cheung, F., Yadav, S., Patel, P., Geoffrois, L., Niolat, J., Berkowitz, N., Marker, M., Chen, D., Motzer, R.J.
Published in Annals of oncology (01.06.2017)
Published in Annals of oncology (01.06.2017)
Get full text
Journal Article
Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis of abiraterone acetate phase III trials
Fizazi, K., Flaig, T.W., Stöckle, M., Scher, H.I., de Bono, J.S., Rathkopf, D.E., Ryan, C.J., Kheoh, T., Li, J., Todd, M.B., Griffin, T.W., Molina, A., Ohlmann, C.H.
Published in Annals of oncology (01.04.2016)
Published in Annals of oncology (01.04.2016)
Get full text
Journal Article
Phase II study of cabazitaxel with or without abiraterone acetate and prednisone in patients with metastatic castrate resistant prostate cancer after prior docetaxel and abiraterone acetate
Kessler, E.R., Gao, D., Flaig, T.W., Breaker, K., Wold, M., Wacker, M., Lam, E.T.
Published in Annals of oncology (01.03.2017)
Published in Annals of oncology (01.03.2017)
Get full text
Journal Article
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
Knox, J J, Barrios, C H, Kim, T M, Cosgriff, T, Srimuninnimit, V, Pittman, K, Sabbatini, R, Rha, S Y, Flaig, T W, Page, R D, Beck, J T, Cheung, F, Yadav, S, Patel, P, Geoffrois, L, Niolat, J, Berkowitz, N, Marker, M, Chen, D, Motzer, R J
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Tivozanib: practical implications for renal cell carcinoma and other solid tumors
Berge, E M, Bowles, D W, Flaig, T W, Lam, E T, Jimeno, A
Published in Drugs of today (Barcelona, Spain : 1998) (01.05.2013)
Published in Drugs of today (Barcelona, Spain : 1998) (01.05.2013)
Get more information
Journal Article
Axitinib, a new therapeutic option in renal cell carcinoma
Kessler, E R, Bowles, D W, Flaig, T W, Lam, E T, Jimeno, A
Published in Drugs of today (Barcelona, Spain : 1998) (01.10.2012)
Published in Drugs of today (Barcelona, Spain : 1998) (01.10.2012)
Get more information
Journal Article
DAB 389 EGF for the treatment of superficial urothelial cancer
Flaig, T. W., Su, L., Thorburn, A., Frankel, A. E., Li, Y., Woo, J. H., Varella-Garcia, M., La Rosa, F. G., Li, C., Yang, X.
Published in Journal of clinical oncology (01.03.2011)
Published in Journal of clinical oncology (01.03.2011)
Get full text
Journal Article
Safety and efficacy of sequencing high-dose interleukin 2 (IL2) after tyrosine kinase inhibitor (TKI) therapy for metastatic renal cell carcinoma
Lam, E. T., Wong, M. K. K., Agarwal, N., Redman, B. G., Logan, T., Flaig, T. W., Monk, J. P., Jarkowski, A., Sendilnathan, A., Bolden, M., Kuzel, T., Olencki, T.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
A phase I safety and tolerability study of vorinostat (V) in combination with sorafenib (S) in patients with advanced solid tumors, with exploration of two tumor-type specific expanded cohorts at the recommended phase II dose (renal and non-small cell lung carcinoma)
Dasari, A., Gore, L., Messersmith, W. A., Diab, S., Jimeno, A., Weekes, C. D., Lewis, K. D., Drabkin, H. A., Flaig, T. W., Camidge, D. R.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Erlotinib with sirolimus for advanced renal cell carcinoma: Preliminary efficacy results
Flaig, T. W., Costa, L., Breaker, K., Schultz, M., Crighton, F., Kim, F. J., Drabkin, H. A.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article